Main Menu

Video: Developing therapeutic ultrasound

Professor Gail ter Haar leads the Therapeutic Ultrasound Team at the ICR. She is investigating the use of high intensity focused ultrasound (HIFU) for treating cancers in the brain and abdomen.

Professor ter Haar is the founding President of the International Society for Therapy Ultrasound (ISTU). Her team is recognised as a Centre of Excellence for HIFU physics and bone studies by the Focused Ultrasound Foundation.

Her team’s work centres on understanding the way that medical ultrasound interacts with tissues, especially the physical mechanisms – such as heating – that can lead to cell death. Most recently, their research has concentrated on developing devices and protocols for targeted ultrasound-based treatments for cancer.

They are working with industrial partners to help advance their research and get new techniques to patients faster. For example, one recent collaboration has provided the team with a clinical imaging system that has enabled cutting-edge clinical trials of HIFU in patients.


Watch more videos of our researchers

Working with pharmaceutical companies

Dr Marco Gerlinger talking about working with pharmaceutical companies

Dr Marco Gerlinger's Translational Oncogenomics Team are keen to develop new partnerships to continue their work, and to access drugs that could reverse the resistance mechanisms that the team has identified so far.


New partnerships in cancer epigenetics

Professor Jessica Downs

Our Epigenetics and Genome Stability team, led by Professor Jessica Downs, is working on a variety of research programmes that could be developed in collaboration with commercial partners.


Sharing experience with industry partners

Dr Paul Huang

Our Molecular and Systems Oncology Team, led by Dr Paul Huang, is keen to collaborate with industry partners on a number of projects on biochemistry, computational modelling, molecular pathology and proteomics.


Collaborating with commercial partners

Dr Anguraj Sadanandam

Our Systems and Precision Cancer Medicine team, led by Dr Anguraj Sadanandam, is investigating ways to stratify tumours based on their genetic and clinical diversity.


Exploring new opportunities for collaborative working

Professor Uwe Oelfke

Professor Uwe Oelfke, Deputy Head of the Division of Radiotherapy and Imaging, is keen to explore new opportunities for collaborative working with industry.


The benefits of partnering with industry

Dr Igor Vivanco

Our Molecular Addictions team, led by Dr Igor Vivanco, is working on a variety of projects that could be developed in collaboration with commercial partners.


Connections newsletter

Sign up to our new quarterly newsletter for updates on our Business and Innovation Office and news about working with industry.